XAV-939 No Further a Mystery
Effects of the next comparative review were reported by Flinn et al. This is a stage III randomized Intergroup trial comparing FC program versus FAMP alone in 278 sufferers receiving their very first chemotherapy routine for B-CLL. Dosages of FC schedule had been the same as the primary research.Retailer at place temperature clear of light-weight a